Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v1-EN
Language English English
Date Updated 2022-08-06 2022-07-13
Drug Identification Number 02047667 02047667
Brand name MERSYNDOL WITH CODEINE MERSYNDOL WITH CODEINE
Common or Proper name acetaminophen, codeine phosphate and doxylamine succinate acetaminophen, codeine phosphate and doxylamine succinate
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients DOXYLAMINE SUCCINATE CODEINE PHOSPHATE ACETAMINOPHEN DOXYLAMINE SUCCINATE CODEINE PHOSPHATE ACETAMINOPHEN
Strength(s) 5MG 8MG 325MG 5MG 8MG 325MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size HDPE bottles of 100 tablets HDPE bottles of 100 tablets
ATC code N02BE N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-07-28 2022-07-28
Actual start date 2022-07-22
Estimated end date 2022-08-08 2022-08-08
Actual end date 2022-08-05
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments